EverPoint Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

EverPoint Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$560K	Buy	+45,000	New	+$542K	0.01%	388

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

EverPoint Asset Management's ARIA Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Ariad Pharmaceuticals Inc (ARIA) in Q4 2016: 45,000 shares worth $560K. The stake represents 0.01% of the portfolio and ranks #388 among its holdings.

200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

EverPoint Asset Management held 45,000 shares of Ariad Pharmaceuticals Inc worth $560K as of Q4 2016.
Ariad Pharmaceuticals Inc was a new EverPoint Asset Management position in Q4 2016.
Ariad Pharmaceuticals Inc made up 0.01% of EverPoint Asset Management's portfolio in Q4 2016, its #388 holding.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.